Insider Selling: National HealthCare (NYSEAMERICAN:NHC) CFO Sells 6,813 Shares

National HealthCare Corporation (NYSEAMERICAN:NHC) CFO Brian Kidd sold 6,813 shares of the company’s stock in a transaction on Friday, September 11th. The shares were sold at an average price of $225.70, for a total value of $1,537,694.10. Following the completion of the sale, the chief financial officer owned 23,183 shares of the company’s stock, valued at approximately $5,232,403.10. This trade represents a 22.71% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this hyperlink.

National HealthCare Trading Up 1.5%

NHC stock traded up $3.29 during trading hours on Monday, hitting $227.76. 67,028 shares of the stock traded hands, compared to its average volume of 110,383. The stock has a 50-day simple moving average of $221.96 and a 200 day simple moving average of $194.09. The company has a market cap of $3.57 billion, a P/E ratio of 25.62 and a beta of 0.62. National HealthCare Corporation has a one year low of $114.59 and a one year high of $239.29.

National HealthCare (NYSEAMERICAN:NHC) last issued its quarterly earnings results on Thursday, August 6th. The company reported $1.74 EPS for the quarter. National HealthCare had a net margin of 9.00% and a return on equity of 10.03%. The firm had revenue of $408.03 million for the quarter.

National HealthCare Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Friday, October 30th. Investors of record on Wednesday, September 30th will be issued a $0.67 dividend. This represents a $2.68 dividend on an annualized basis and a dividend yield of 1.2%. The ex-dividend date is Wednesday, September 30th. National HealthCare’s payout ratio is presently 61.89%.

Analyst Ratings Changes

A number of analysts recently weighed in on NHC shares. BMO Capital Markets upgraded shares of National HealthCare to a “hold” rating in a report on Monday, May 18th. The Goldman Sachs Group upgraded National HealthCare to a “strong-buy” rating in a research report on Monday, May 18th. Royal Bank Of Canada raised National HealthCare to a “hold” rating in a research note on Monday, May 18th. Finally, Robert W. Baird raised National HealthCare to a “strong-buy” rating in a research report on Monday, May 18th. Two equities research analysts have rated the stock with a Strong Buy rating and two have issued a Hold rating to the company. According to data from MarketBeat.com, National HealthCare has an average rating of “Buy”.

Hedge Funds Weigh In On National HealthCare

Hedge funds and other institutional investors have recently added to or reduced their stakes in the company. Tidal Investments LLC acquired a new stake in National HealthCare during the 2nd quarter valued at $346,000. Squarepoint Ops LLC acquired a new stake in shares of National HealthCare in the second quarter worth $482,000. Nykredit A S purchased a new position in shares of National HealthCare during the second quarter valued at $207,000. Corient Private Wealth LP grew its holdings in shares of National HealthCare by 158.6% during the second quarter. Corient Private Wealth LP now owns 11,825 shares of the company’s stock valued at $2,499,000 after buying an additional 7,252 shares in the last quarter. Finally, Amundi acquired a new position in National HealthCare during the second quarter valued at $297,000. Institutional investors and hedge funds own 56.44% of the company’s stock.

About National HealthCare

National HealthCare Corporation (NHC) is a provider of post-acute health care and senior living services headquartered in Murfreesboro, Tennessee. The company operates skilled nursing and rehabilitation centers, assisted living and retirement communities, and other services designed to support patients and residents who need short-term recovery, long-term care or assistance with daily living.

NHC also provides home health, hospice and palliative care, behavioral health services, and pharmacy services.